Calder M A, Croughan M J, McLeod D T, Ahmad F
Drugs. 1986;31 Suppl 3:11-6. doi: 10.2165/00003495-198600313-00005.
The incidence of Branhamella catarrhalis in respiratory infections at City Hospital, Edinburgh from January 1981 to April 1984 is described. Beginning in January 1982 there was an increased incidence associated with a high proportion of beta-lactamase-producing strains. The number of these strains increased: from January 1981 to April 1983, 61% of strains produced beta-lactamase, and 83% produced beta-lactamase from January to April 1984. 53% of patients were infected in hospital. Environmental studies showed that 7% of staff and 8% of patients were carriers; there was also circumstantial evidence of ward and patient-to-patient infection. The antimicrobial susceptibility of 54 clinical strains was tested: all strains were resistant to trimethoprim but were susceptible to clavulanic acid plus amoxycillin, chloramphenicol, erythromycin, co-trimoxazole, cefotaxime and cefuroxime. beta-Lactamase-negative strains were uniformly susceptible to penicillin and ampicillin.
本文描述了1981年1月至1984年4月间,爱丁堡市立医院呼吸道感染中卡他布兰汉菌的发病率。从1982年1月开始,发病率上升,且产β-内酰胺酶菌株的比例很高。这些菌株的数量不断增加:1981年1月至1983年4月,61%的菌株产β-内酰胺酶,而在1984年1月至4月,这一比例为83%。53%的患者是在医院感染的。环境研究表明,7%的工作人员和8%的患者是携带者;也有间接证据表明存在病房内感染和患者之间的感染。对54株临床菌株进行了药敏试验:所有菌株对甲氧苄啶耐药,但对克拉维酸加阿莫西林、氯霉素、红霉素、复方新诺明、头孢噻肟和头孢呋辛敏感。β-内酰胺酶阴性菌株对青霉素和氨苄西林均敏感。